Fusion Pharmaceuticals Price on September 30, 2023
FUSNDelisted Stock | USD 3.75 0.33 8.09% |
If you're considering investing in Fusion Stock, it is important to understand the factors that can impact its price. As of today, the current price of Fusion Pharmaceuticals stands at 3.75, as last reported on the 28th of November, with the highest price reaching 4.08 and the lowest price hitting 3.75 during the day. We have found eight technical indicators for Fusion Pharmaceuticals, which you can use to evaluate the volatility of the firm. Please confirm Fusion Pharmaceuticals' Day Typical Price of 3.86, market facilitation index of 0.33, and Rate Of Daily Change of 0.92 to check if the risk estimate we provide is consistent with the expected return of 0.0%.
Fusion Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
Fusion |
Sharpe Ratio = 0.0
Best Portfolio | Best Equity | |||
Good Returns | ||||
Average Returns | ||||
Small Returns | ||||
Cash | Small Risk | Average Risk | High Risk | Huge Risk |
FUSN |
Based on monthly moving average Fusion Pharmaceuticals is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Fusion Pharmaceuticals by adding Fusion Pharmaceuticals to a well-diversified portfolio.
Fusion Pharmaceuticals Valuation on September 30, 2023
It is possible to determine the worth of Fusion Pharmaceuticals on a given historical date. On September 30, 2023 Fusion was worth 4.08 at the beginning of the trading date compared to the closed value of 3.75. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Fusion Pharmaceuticals stock. Still, in general, we apply an absolute valuation method to find Fusion Pharmaceuticals' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Fusion Pharmaceuticals where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Fusion Pharmaceuticals' related companies.
Open | High | Low | Close | Volume | |
4.03 | 4.17 | 3.93 | 4.10 | 23,788 | |
07/24/2023 | 4.08 | 4.08 | 3.75 | 3.75 | 108,815 |
4.08 | 4.08 | 3.75 | 3.75 | 0.00 |
Backtest Fusion Pharmaceuticals | | | Fusion Pharmaceuticals History | | | Fusion Pharmaceuticals Valuation | Previous | Next |
Fusion Pharmaceuticals Trading Date Momentum on September 30, 2023
On November 28 2024 Fusion Pharmaceuticals was traded for 3.75 at the closing time. The top price for the day was 4.08 and the lowest listed price was 3.75 . There was no trading activity during the period 0.0. Lack of trading volume on November 28, 2024 did not affect price variability. The overall trading delta against the current closing price is 8.80% . |
Fusion Pharmaceuticals Fundamentals Correlations and Trends
By evaluating Fusion Pharmaceuticals' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Fusion Pharmaceuticals' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Fusion financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Fusion Pharmaceuticals Stock history
Fusion Pharmaceuticals investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Fusion is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Fusion Pharmaceuticals will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Fusion Pharmaceuticals stock prices may prove useful in developing a viable investing in Fusion Pharmaceuticals
Fusion Pharmaceuticals Inc., a clinical-stage oncology company, focuses on developing radiopharmaceuticals as precision medicines. Fusion Pharmaceuticals Inc. was incorporated in 2014 and is headquartered in Hamilton, Canada. Fusion Pharmaceuticals is traded on NASDAQ Exchange in the United States.
Fusion Pharmaceuticals Stock Technical Analysis
Fusion Pharmaceuticals technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, delisted stock market cycles, or different charting patterns.
Price Boundaries
Fusion Pharmaceuticals Period Price Range
Low | November 28, 2024
| High |
0.00 | 0.00 |
Fusion Pharmaceuticals cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Fusion Pharmaceuticals November 28, 2024 Market Strength
Market strength indicators help investors to evaluate how Fusion Pharmaceuticals stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Fusion Pharmaceuticals shares will generate the highest return on investment. By undertsting and applying Fusion Pharmaceuticals stock market strength indicators, traders can identify Fusion Pharmaceuticals entry and exit signals to maximize returns
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state. You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.
Other Consideration for investing in Fusion Stock
If you are still planning to invest in Fusion Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Fusion Pharmaceuticals' history and understand the potential risks before investing.
AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope |